Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$29.21
-0.15-0.51%
After hour: 4:05 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Bath & Body Works Inc ha un obiettivo di prezzo di consenso pari a $40.47, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da UBS, Barclays y Telsey Advisory Group il agosto 29, 2025, agosto 29, 2025 y agosto 28, 2025. Con un obiettivo di prezzo medio di $34 tra le UBS, Barclays y Telsey Advisory Group, c'è un implicito 16.40% upside per Bath & Body Works Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
UBS
Barclays
Telsey Advisory Group
Citigroup
JP Morgan
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Bath & Body Works
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/29/2025 | 9.55% | UBS | $36 → $32 | Maintains | Neutral | |||
08/29/2025 | 9.55% | Barclays | $30 → $32 | Maintains | Equal-Weight | |||
08/28/2025 | 30.09% | Telsey Advisory Group | $38 → $38 | Maintains | Outperform | |||
08/21/2025 | 30.09% | Telsey Advisory Group | $38 → $38 | Maintains | Outperform | |||
08/19/2025 | 36.94% | Citigroup | $42 → $40 | Maintains | Buy | |||
07/28/2025 | 57.48% | JP Morgan | $40 → $46 | Maintains | Overweight | |||
05/30/2025 | 2.7% | Barclays | $35 → $30 | Maintains | Equal-Weight | |||
05/30/2025 | 47.21% | Goldman Sachs | $44 → $43 | Maintains | Buy | |||
05/30/2025 | 30.09% | Telsey Advisory Group | $43 → $38 | Maintains | Outperform | |||
05/29/2025 | 47.21% | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
05/20/2025 | 43.79% | Citigroup | $36 → $42 | Maintains | Buy | |||
05/20/2025 | 23.25% | UBS | $32 → $36 | Maintains | Neutral | |||
05/20/2025 | 19.82% | Barclays | $31 → $35 | Maintains | Equal-Weight | |||
05/20/2025 | 47.21% | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
05/19/2025 | 47.21% | JP Morgan | $41 → $43 | Maintains | Overweight | |||
05/14/2025 | 50.63% | Wells Fargo | $40 → $44 | Maintains | Overweight | |||
05/12/2025 | 6.13% | Barclays | $38 → $31 | Maintains | Equal-Weight | |||
05/06/2025 | 47.21% | Morgan Stanley | $49 → $43 | Maintains | Overweight | |||
04/30/2025 | 36.94% | Wells Fargo | $48 → $40 | Maintains | Overweight | |||
04/22/2025 | 43.79% | Goldman Sachs | $49 → $42 | Maintains | Buy | |||
04/17/2025 | 26.67% | Raymond James | $46 → $37 | Maintains | Outperform | |||
04/14/2025 | 40.36% | JP Morgan | $47 → $41 | Maintains | Overweight | |||
04/09/2025 | 19.82% | Piper Sandler | $38 → $35 | Upgrade | Neutral → Overweight | |||
04/07/2025 | 23.25% | Citigroup | $48 → $36 | Maintains | Buy | |||
03/03/2025 | 30.09% | Barclays | $43 → $38 | Maintains | Equal-Weight | |||
02/28/2025 | 33.52% | UBS | $42 → $39 | Maintains | Neutral | |||
02/28/2025 | 60.9% | Baird | $45 → $47 | Maintains | Outperform | |||
02/28/2025 | 64.33% | Citigroup | $40 → $48 | Upgrade | Neutral → Buy | |||
02/28/2025 | 47.21% | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/27/2025 | 47.21% | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/25/2025 | 57.48% | Raymond James | $42 → $46 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 47.21% | Barclays | $34 → $43 | Upgrade | Underweight → Equal-Weight | |||
02/20/2025 | 47.21% | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/18/2025 | 60.9% | JP Morgan | $41 → $47 | Upgrade | Neutral → Overweight | |||
01/24/2025 | 40.36% | JP Morgan | $39 → $41 | Maintains | Neutral | |||
01/10/2025 | — | Argus Research | — | Maintains | Hold | |||
01/10/2025 | 64.33% | Wells Fargo | $42 → $48 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 33.52% | Piper Sandler | $36 → $39 | Maintains | Neutral | |||
12/12/2024 | 64.33% | TD Cowen | $42 → $48 | Maintains | Buy | |||
12/12/2024 | 43.79% | Wells Fargo | $38 → $42 | Maintains | Equal-Weight | |||
11/26/2024 | 36.94% | UBS | $38 → $40 | Maintains | Neutral | |||
11/26/2024 | 43.79% | TD Cowen | $40 → $42 | Maintains | Buy | |||
11/26/2024 | 47.21% | Telsey Advisory Group | $42 → $43 | Maintains | Outperform | |||
11/26/2024 | 67.75% | Morgan Stanley | $48 → $49 | Maintains | Overweight | |||
11/26/2024 | 78.02% | Deutsche Bank | $51 → $52 | Maintains | Buy | |||
11/26/2024 | 30.09% | Wells Fargo | $32 → $38 | Maintains | Equal-Weight | |||
11/26/2024 | 33.52% | JP Morgan | $35 → $39 | Maintains | Neutral | |||
11/26/2024 | 16.4% | Barclays | $28 → $34 | Maintains | Underweight | |||
11/26/2024 | 23.25% | Piper Sandler | $35 → $36 | Maintains | Neutral | |||
11/25/2024 | 43.79% | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
11/18/2024 | 43.79% | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
11/08/2024 | -4.14% | Barclays | $31 → $28 | Downgrade | Equal-Weight → Underweight | |||
11/06/2024 | 9.55% | Wells Fargo | $35 → $32 | Maintains | Equal-Weight | |||
09/26/2024 | 43.79% | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
09/05/2024 | 74.6% | Morgan Stanley | $56 → $51 | Maintains | Overweight | |||
08/29/2024 | 43.79% | Telsey Advisory Group | $53 → $42 | Maintains | Outperform | |||
08/29/2024 | 71.17% | BMO Capital | $52 → $50 | Reiterates | Outperform → Outperform | |||
08/29/2024 | 67.75% | Goldman Sachs | $60 → $49 | Maintains | Buy | |||
08/29/2024 | 33.52% | JP Morgan | $42 → $39 | Maintains | Neutral | |||
08/29/2024 | 43.79% | Raymond James | $51 → $42 | Maintains | Outperform | |||
08/29/2024 | 6.13% | Barclays | $32 → $31 | Maintains | Equal-Weight | |||
08/29/2024 | 30.09% | UBS | $52 → $38 | Maintains | Neutral | |||
08/29/2024 | 54.06% | B of A Securities | $54 → $45 | Maintains | Buy | |||
08/29/2024 | 54.06% | Baird | $54 → $45 | Maintains | Outperform | |||
08/28/2024 | 81.44% | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
08/28/2024 | 19.82% | Evercore ISI Group | $45 → $35 | Maintains | In-Line | |||
08/26/2024 | 84.87% | Deutsche Bank | $57 → $54 | Maintains | Buy | |||
08/21/2024 | 81.44% | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
08/20/2024 | 19.82% | Citigroup | $48 → $35 | Maintains | Neutral | |||
08/07/2024 | 9.55% | Barclays | $45 → $32 | Maintains | Equal-Weight | |||
07/24/2024 | 36.94% | Wells Fargo | $48 → $40 | Maintains | Equal-Weight | |||
07/11/2024 | 33.52% | Piper Sandler | $47 → $39 | Maintains | Neutral | |||
06/05/2024 | 88.29% | BMO Capital | $50 → $55 | Maintains | Outperform | |||
06/04/2024 | 81.44% | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
05/29/2024 | 81.44% | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
05/17/2024 | 81.44% | JP Morgan | $40 → $53 | Upgrade | Underweight → Neutral | |||
04/24/2024 | 64.33% | Wells Fargo | $42 → $48 | Maintains | Equal-Weight | |||
04/09/2024 | 54.06% | Piper Sandler | $44 → $45 | Maintains | Neutral | |||
04/05/2024 | 81.44% | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
03/04/2024 | 91.72% | Goldman Sachs | $49 → $56 | Maintains | Buy | |||
03/04/2024 | 78.02% | UBS | $46 → $52 | Maintains | Neutral | |||
03/01/2024 | 43.79% | Wells Fargo | $40 → $42 | Maintains | Equal-Weight | |||
03/01/2024 | 84.87% | Baird | $50 → $54 | Maintains | Outperform | |||
03/01/2024 | 71.17% | BMO Capital | $48 → $50 | Maintains | Outperform | |||
03/01/2024 | 88.29% | TD Cowen | $35 → $55 | Maintains | Outperform | |||
03/01/2024 | 54.06% | Evercore ISI Group | $30 → $45 | Maintains | In-Line | |||
03/01/2024 | 81.44% | Telsey Advisory Group | $50 → $53 | Maintains | Outperform | |||
02/29/2024 | 71.17% | Telsey Advisory Group | → $50 | Reiterates | Outperform → Outperform | |||
02/22/2024 | 71.17% | Telsey Advisory Group | → $50 | Reiterates | Outperform → Outperform | |||
02/14/2024 | 57.48% | UBS | $44 → $46 | Maintains | Neutral | |||
01/04/2024 | 54.06% | Barclays | $37 → $45 | Downgrade | Overweight → Equal-Weight | |||
01/02/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
12/22/2023 | 36.94% | Wells Fargo | $35 → $40 | Maintains | Equal-Weight | |||
11/17/2023 | 2.7% | Evercore ISI Group | $40 → $30 | Maintains | In-Line | |||
11/17/2023 | 43.79% | Telsey Advisory Group | $52 → $42 | Maintains | Outperform | |||
10/26/2023 | 2.7% | Jefferies | $45 → $30 | Downgrade | Buy → Hold | |||
10/24/2023 | -7.57% | JP Morgan | → $27 | Downgrade | Neutral → Underweight | |||
10/23/2023 | 36.94% | Raymond James | $48 → $40 | Maintains | Outperform | |||
08/24/2023 | 33.52% | UBS | $38 → $39 | Maintains | Neutral | |||
08/24/2023 | 78.02% | Telsey Advisory Group | → $52 | Reiterates | Outperform → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Bath & Body Works (BBWI)?
El último precio objetivo de Bath & Body Works (NYSE:BBWI) fue comunicado por UBS el agosto 29, 2025. La firma de analistas fijó un precio objetivo para $32.00 que espera BBWI a rise dentro de 12 meses (un posible 9.55% upside). 55 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Bath & Body Works (BBWI)?
La última calificación de analistas para Bath & Body Works (NYSE:BBWI) fue proporcionada por UBS, y Bath & Body Works mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Bath & Body Works (BBWI)?
La última revisión al alza de Bath & Body Works Inc se produjo en abril 9, 2025, cuando Piper Sandler elevó su precio objetivo a $35. Piper Sandler anteriormente tenía a neutral para Bath & Body Works Inc.
¿Cuándo fue la última revisión a la baja de Bath & Body Works (BBWI)?
La última revisión a la baja de Bath & Body Works Inc se produjo en noviembre 8, 2024, cuando Barclays cambió su precio objetivo de $31 a $28 para Bath & Body Works Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Bath & Body Works (BBWI)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Bath & Body Works, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Bath & Body Works se registró el agosto 29, 2025, por lo que la próxima calificación estará disponible en torno al agosto 29, 2026.
¿Es correcta la calificación de los analistas sobre Bath & Body Works (BBWI)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Bath & Body Works (BBWI) fue un mantuvo con un precio objetivo de $36.00 a $32.00. El precio actual al que cotiza Bath & Body Works (BBWI) es de $29.21, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.